erlotinib hydrochloride has been researched along with carvedilol in 1 studies
Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (carvedilol) | Trials (carvedilol) | Recent Studies (post-2010) (carvedilol) |
---|---|---|---|---|---|
4,353 | 786 | 3,033 | 2,933 | 680 | 1,052 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Kim, IM; Rockman, HA; Salazar, NC; Tilley, DG; Violin, JD; Whalen, EJ | 1 |
1 other study(ies) available for erlotinib hydrochloride and carvedilol
Article | Year |
---|---|
Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Arrestins; beta-Arrestins; Carbazoles; Carvedilol; Cell Line, Transformed; Dose-Response Relationship, Drug; Enzyme Activation; Enzymes; ErbB Receptors; Erlotinib Hydrochloride; Genes, erbB-1; Heart; Humans; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Propanolamines; Quinazolines; Signal Transduction; Transcriptional Activation | 2008 |